{"id":533837,"date":"2021-09-02T08:38:06","date_gmt":"2021-09-02T12:38:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/"},"modified":"2021-09-02T08:38:06","modified_gmt":"2021-09-02T12:38:06","slug":"infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/","title":{"rendered":"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences<\/b><\/p>\n<p>CAMBRIDGE, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.infi.com%2F&amp;esheet=52485520&amp;newsitemid=20210902005247&amp;lan=en-US&amp;anchor=Infinity+Pharmaceuticals%2C+Inc&amp;index=1&amp;md5=9c92af06fceb1e5455e99cdc89e73bc0\">Infinity Pharmaceuticals, Inc<\/a>. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, today announced that the Company will participate in Wells Fargo\u2019s Virtual Healthcare Conference and H.C. Wainwright\u2019s 23<sup>rd<\/sup> Annual Global Investment Conference being held virtually.\n<\/p>\n<p>\nPresentation details can be found below:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Wells Fargo Virtual Healthcare Conference<br \/>\n<br \/><\/b>Format: Fireside chat and 1-on-1 meetings<br \/>\n<br \/>Date and Time: Fireside chat September 9 <sup>th<\/sup> at 2:40pm ET; 1-on-1 meetings September 9-10<br \/>\n<br \/>Webcast Link: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fkvgo.com%2Fwells-fargo%2Finfinity-pharmaceuticals-sept-2021&amp;esheet=52485520&amp;newsitemid=20210902005247&amp;lan=en-US&amp;anchor=https%3A%2F%2Fkvgo.com%2Fwells-fargo%2Finfinity-pharmaceuticals-sept-2021&amp;index=2&amp;md5=ed86db98eb88a807a06620f2704ea3fa\">https:\/\/kvgo.com\/wells-fargo\/infinity-pharmaceuticals-sept-2021<\/a><\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>H.C. Wainwright Virtual 23<sup>rd<\/sup> Annual Global Investment Conference<br \/>\n<br \/><\/b>Format: On demand presentation and 1-on-1 meetings<br \/>\n<br \/>Date and Time: Presentation available Monday, September 13 <sup>th<\/sup> 7am ET; 1-on-1 meetings September 13-15<br \/>\n<br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmy.ct.events%2Fregister.aspx%3Fmeid%3Db4a701b0-71a0-4667-9082-299f545e8cf8%26rpid%3Df0d11ebc-486e-4073-8ea7-9bb41337715e&amp;esheet=52485520&amp;newsitemid=20210902005247&amp;lan=en-US&amp;anchor=Registration+Link&amp;index=3&amp;md5=9fa7dd9c63ac613f878b9fdb32675487\">Registration Link<\/a><\/li>\n<\/ul>\n<p><i>The presentations and archived webcasts can be accessed in the Investors\/Media section of Infinity&#8217;s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.infi.com%2F&amp;esheet=52485520&amp;newsitemid=20210902005247&amp;lan=en-US&amp;anchor=www.infi.com&amp;index=4&amp;md5=a2d4d5f40eca2d6016c2443a7309fc3c\">www.infi.com<\/a> and will be available on Infinity&#8217;s website for 30 days following the event.<\/i><\/p>\n<p><b>About Infinity and Eganelisib <\/b><\/p>\n<p>\nInfinity Pharmaceuticals, Inc. (\u201cInfinity\u201d or the \u201cCompany\u201d), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies. MARIO-275 is a randomized, controlled combination study of eganelisib combined with Opdivo<sup>\u00ae<\/sup> in I\/O na\u00efve urothelial cancer. MARIO-3 is the first eganelisib combination study in front-line advanced cancer patients and is evaluating eganelisib in combination with Tecentriq<sup>\u00ae<\/sup> and Abraxane<sup>\u00ae<\/sup> in front-line TNBC and in combination with Tecentriq and Avastin<sup>\u00ae<\/sup> in front-line RCC. In collaboration with Arcus Biosciences, Infinity is evaluating a checkpoint inhibitor-free, novel combination regimen of eganelisib plus etrumadenant (AB928, a dual adenosine receptor antagonist) plus Doxil<sup>\u00ae<\/sup> in advanced TNBC patients. In 2019, Infinity completed enrollment in MARIO-1, a Phase 1\/1b study evaluating eganelisib as a monotherapy and in combination with Opdivo (nivolumab) in patients with advanced solid tumors including patients refractory to checkpoint inhibitor therapy. With these studies Infinity is evaluating eganelisib in the anti-PD-1 refractory, I\/O-na\u00efve, and front-line settings. For more information on Infinity, please refer to Infinity&#8217;s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.infi.com%2F&amp;esheet=52485520&amp;newsitemid=20210902005247&amp;lan=en-US&amp;anchor=www.infi.com&amp;index=5&amp;md5=adc48682cc1233cf91d9fb7b41d66c57\">www.infi.com<\/a>.\n<\/p>\n<p>\nOpdivo<sup>\u00ae<\/sup> is a registered trademark of Bristol Myers Squibb.<br \/>\n<br \/>Tecentriq<sup>\u00ae<\/sup> is a registered trademark of Genentech, Inc.<br \/>\n<br \/>Abraxane<sup>\u00ae<\/sup> is a registered trademark of Abraxis BioScience, LLC., a wholly owned subsidiary of Bristol Myers Squibb Company.<br \/>\n<br \/>Avastin<sup>\u00ae<\/sup> is a registered trademark of Genentech, Inc.<br \/>\n<br \/>Doxil<sup>\u00ae<\/sup> is a registered trademark of Baxter Healthcare Corporation.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210902005247\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210902005247\/en\/<\/a><\/span><\/p>\n<p>\nInvestor Relations:<br \/>\n<br \/>Irina Koffler<br \/>\n<br \/>LifeSci Advisors, LLC<br \/>\n<br \/>646-970-4681<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ikoffler@lifesciadvisors.com\">ikoffler@lifesciadvisors.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Oncology Health Clinical Trials General Health Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, today announced that the Company will participate in Wells Fargo\u2019s Virtual Healthcare Conference and H.C. Wainwright\u2019s 23rd Annual Global Investment Conference being held virtually. Presentation details can be found below: Wells Fargo Virtual Healthcare Conference Format: Fireside chat and 1-on-1 meetings Date and Time: Fireside chat September 9 th at 2:40pm ET; 1-on-1 meetings September 9-10 Webcast Link: https:\/\/kvgo.com\/wells-fargo\/infinity-pharmaceuticals-sept-2021 H.C. Wainwright Virtual 23rd Annual Global Investment Conference Format: On demand presentation and 1-on-1 meetings Date and Time: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533837","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, today announced that the Company will participate in Wells Fargo\u2019s Virtual Healthcare Conference and H.C. Wainwright\u2019s 23rd Annual Global Investment Conference being held virtually. Presentation details can be found below: Wells Fargo Virtual Healthcare Conference Format: Fireside chat and 1-on-1 meetings Date and Time: Fireside chat September 9 th at 2:40pm ET; 1-on-1 meetings September 9-10 Webcast Link: https:\/\/kvgo.com\/wells-fargo\/infinity-pharmaceuticals-sept-2021 H.C. Wainwright Virtual 23rd Annual Global Investment Conference Format: On demand presentation and 1-on-1 meetings Date and Time: &hellip; Continue reading &quot;Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T12:38:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences\",\"datePublished\":\"2021-09-02T12:38:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/\"},\"wordCount\":473,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/\",\"name\":\"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-02T12:38:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences - Market Newsdesk","og_description":"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, today announced that the Company will participate in Wells Fargo\u2019s Virtual Healthcare Conference and H.C. Wainwright\u2019s 23rd Annual Global Investment Conference being held virtually. Presentation details can be found below: Wells Fargo Virtual Healthcare Conference Format: Fireside chat and 1-on-1 meetings Date and Time: Fireside chat September 9 th at 2:40pm ET; 1-on-1 meetings September 9-10 Webcast Link: https:\/\/kvgo.com\/wells-fargo\/infinity-pharmaceuticals-sept-2021 H.C. Wainwright Virtual 23rd Annual Global Investment Conference Format: On demand presentation and 1-on-1 meetings Date and Time: &hellip; Continue reading \"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T12:38:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences","datePublished":"2021-09-02T12:38:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/"},"wordCount":473,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/","name":"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-02T12:38:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210902005247r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/infinity-to-participate-in-wells-fargo-and-h-c-wainwright-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533837"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533837\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}